McKESSON CORPORATION income statement MCK

In fiscal 2026, which ended Mar 31, 2026, McKESSON CORPORATION reported revenue of $403.4 billion, up 12.4% from the year before. Net income was $4.8 billion, a profit margin of 1.2%. Operating income came to $6.2 billion, an operating margin of 1.5%. Diluted earnings per share were $38.38. Over the twelve months ended Sep 30, 2026, revenue was $418.8 billion and net income was $4.7 billion. Across the 10 fiscal years shown, revenue grew from $198.5 billion in fiscal 2017 to $403.4 billion in fiscal 2026, about 8.2% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2027
Sep 30, 2026
FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
FY 2023
Mar 31, 2023
FY 2022
Mar 31, 2022
FY 2021
Mar 31, 2021
FY 2020
Mar 31, 2020
FY 2019
Mar 31, 2019
FY 2018
Mar 31, 2018
FY 2017
Mar 31, 2017
Revenue
418,790
+8.2%
403,430
+12.4%
359,051
+16.2%
308,951
+11.7%
276,711
+4.8%
263,966
+10.8%
238,228
+3.1%
231,051
+7.8%
214,319
+2.9%
208,357
+4.9%
198,533
+4.0%
Cost of revenue
403,420
+8.1%
388,880
+12.5%
345,728
+16.8%
296,123
+12.0%
264,353
+5.4%
250,836
+11.0%
226,080
+3.2%
219,028
+8.1%
202,565
+2.7%
197,173
+5.3%
187,262
+4.3%
Gross profit
15,370
+11.8%
14,550
+9.2%
13,323
+3.9%
12,828
+3.8%
12,358
-5.9%
13,130
+8.1%
12,148
+1.0%
12,023
+2.3%
11,754
+5.1%
11,184
-0.8%
11,271
-1.3%
Research and development
—
—
—
—
—
—
—
96
+35.2%
71
-43.2%
125
-63.3%
341
-13.0%
Selling, general and administrative
8,359
+1.0%
8,096
-4.8%
8,507
-1.7%
8,657
+11.3%
7,776
-26.2%
10,537
+19.1%
8,849
-3.6%
9,182
+8.8%
8,437
+3.7%
8,138
+9.3%
7,447
+0.9%
Restructuring and impairment
356
+69.5%
245
-28.8%
344
+199.1%
115
-45.0%
209
-14.7%
245
+11.9%
219
—
—
13
-7.1%
14
-93.9%
Operating income
6,692
+27.3%
6,212
+40.5%
4,422
+13.1%
3,909
-10.8%
4,381
+115.0%
2,038
+140.4%
-5,040
-302.5%
2,489
+180.9%
886
+16.3%
762
-89.3%
7,122
+100.9%
Interest expense
306
+30.2%
247
-6.8%
265
—
—
—
—
—
—
—
—
Other income (expense)
239
236
+16.8%
202
+53.0%
132
-73.4%
497
+91.9%
259
+16.1%
223
+1758.3%
12
-93.4%
182
+40.0%
130
+68.8%
77
+32.8%
Pretax income
6,625
+27.7%
6,201
+42.3%
4,359
+15.0%
3,789
-18.2%
4,630
+140.1%
1,928
+138.3%
-5,034
-540.0%
1,144
+87.5%
610
+155.2%
239
-96.5%
6,891
+112.0%
Income tax
1,192
+24.3%
1,102
+25.5%
878
+39.6%
629
-30.5%
905
+42.3%
636
+191.5%
-695
-3961.1%
18
-94.9%
356
+771.7%
-53
-103.3%
1,614
+77.8%
Net income
4,700
+16.5%
4,762
+44.5%
3,295
+9.8%
3,002
-15.7%
3,560
+219.6%
1,114
+124.5%
-4,539
-604.3%
900
+2547.1%
34
-49.3%
67
-98.7%
5,070
+124.5%
Basic EPS
39.13
+21.3%
38.55
+49.1%
25.86
+14.7%
22.54
-10.7%
25.23
+244.7%
7.32
+125.9%
-28.26
-667.5%
4.98
+2829.4%
0.17
-46.9%
0.32
-98.6%
22.95
+133.7%
Diluted EPS
38.97
+21.3%
38.38
+49.2%
25.72
+14.9%
22.39
-10.5%
25.03
+246.2%
7.23
+125.6%
-28.26
-670.9%
4.95
+2811.8%
0.17
-46.9%
0.32
-98.6%
22.73
+134.3%
Weighted average shares, basic
120
-3.9%
124
-3.0%
127
-4.4%
133
-5.6%
141
-7.4%
152
-5.2%
161
-11.1%
181
-8.0%
196
-5.6%
208
-5.9%
221
-3.9%
Weighted average shares, diluted
121
-3.9%
124
-3.1%
128
-4.5%
134
-5.7%
142
-7.7%
154
-4.0%
161
-11.6%
182
-8.0%
197
-5.6%
209
-6.3%
223
-4.3%
Other measures
Depreciation and amortization
776
287
+5.5%
272
-2.5%
279
+2.6%
272
-12.8%
312
-9.3%
344
-62.7%
922
-2.8%
949
-0.2%
951
+4.5%
910
+2.8%
EBITDA
7,468
6,499
+38.5%
4,694
+12.1%
4,188
-10.0%
4,653
+98.0%
2,350
+150.0%
-4,696
-237.7%
3,411
+85.9%
1,835
+7.1%
1,713
-78.7%
8,032
+81.3%
Interest coverage
21.87x
25.15x
16.69x
—
—
—
—
—
—
—
—
Margins
Gross margin
3.67%
3.61%
3.71%
4.15%
4.47%
4.97%
5.10%
5.20%
5.48%
5.37%
5.68%
Operating margin
1.60%
1.54%
1.23%
1.27%
1.58%
0.77%
-2.12%
1.08%
0.41%
0.37%
3.59%
Pretax margin
1.58%
1.54%
1.21%
1.23%
1.67%
0.73%
-2.11%
0.50%
0.28%
0.11%
3.47%
Profit margin
1.12%
1.18%
0.92%
0.97%
1.29%
0.42%
-1.91%
0.39%
0.02%
0.03%
2.55%
EBITDA margin
1.78%
1.61%
1.31%
1.36%
1.68%
0.89%
-1.97%
1.48%
0.86%
0.82%
4.05%
Effective tax rate
17.99%
17.77%
20.14%
16.60%
19.55%
32.99%
—
1.57%
58.36%
-22.18%
23.42%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
Listed as
MCK (NYSE)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Irving, TX
SEC filer status
Large accelerated filer
SEC CIK
927653
Former names
MCKESSON HBOC INC (until Aug 13, 2001)

Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.